Tyra Biosciences, Inc. - Common Stock

Tyra Biosciences, Inc. - Common Stock

Share · US90240B1061 · TYRA (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Tyra Biosciences, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
7
0
0
0
No Price
28.04.2026 20:00
Current Prices from Tyra Biosciences, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
TYRA
USD
28.04.2026 20:00
35,06 USD
-1,86 USD
-5,04 %
IEXG: IEX
IEX
TYRA
USD
28.04.2026 19:59
35,05 USD
-1,87 USD
-5,07 %
Share Float & Liquidity
Free Float 68,79 %
Shares Float 36,95 M
Shares Outstanding 53,71 M
Company Profile for Tyra Biosciences, Inc. - Common Stock Share
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Company Data

Name Tyra Biosciences, Inc. - Common Stock
Company Tyra Biosciences, Inc.
Symbol TYRA
Website https://www.tyra.bio
Primary Exchange XNAS NASDAQ
ISIN US90240B1061
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Todd Harris
Market Capitalization 2 Mrd.
Country United States of America
Currency USD
Employees 0,1 T
Address 2656 State Street, 92008 Carlsbad
IPO Date 2021-09-15

Ticker Symbols

Name Symbol
NASDAQ TYRA
More Shares
Investors who hold Tyra Biosciences, Inc. - Common Stock also have the following shares in their portfolio:
LB.HESS.THR.CARRARA09A/16
LB.HESS.THR.CARRARA09A/16 Bond
WESTPAC SECURITIES NZ LIMITED 1.5632% REG S CVD BDS SRS 15-2 29/12/31
WESTPAC SECURITIES NZ LIMITED 1.5632% REG S CVD BDS SRS 15-2 29/12/31 Bond